Position:Senior Research Statistician
Ruth is a Senior Research Statistician at the Diabetes Trials Unit.
Her ongoing projects include the expansion of the UKPDS Risk Engine to include estimates of both cardiovascular and microvascular disease risk, and modelling life expectancy in type 2 diabetes.
She is currently the statistical lead for the ACE study.
The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials
David Preiss et al.
Diabetes Care 2022;45:e1-e2
Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
Marcus Lind et al.
Diabetes Care 2021;44:2231-2237
Predicting the Risk of Developing Type 2 diabetes in Chinese People who have Coronary Heart Disease and Impaired Glucose Tolerance
Shishi Xu et al.
Journal of Diabetes 2021;13:817-826
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Moritz J. Hundertmark et al.
ESC Heart Failure 2021;8:2580-2590
Increased Risk of Incident Heart Failure and Death is Associated with Insulin Resistance in People with Newly- Diagnosed Type 2 Diabetes: UKPDS 89
Malgorzata Wamil et al.
Diabetes Care 2021;44:1-8
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension: A Systematic Review and Individual Participant-based Meta-analysis
Stephen P Juraschek et al.
Ann Int Med. 2020;174:58-68